Latest Piper Jaffray Companies (PJC) Headlines Two

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Piper Jaffray Companies (PJC) Headlines

Two Broker Stocks That Are Poised to Run Higher - Analyst Blog
Brian Hamilton - Zacks Investment Research - Wed Mar 12, 5:35PM CDT
Analysts are also hoping on board this trend.

Balanced View on Morgan Stanley - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:40PM CDT
This leading financial services holding company recently reported better-than-expected fourth-quarter 2013 results.

Piper Jaffray Hires Ruben Roy to Expand Semiconductor and Semiconductor Capital Equipment Research Platform
Business Wire - Fri Mar 07, 11:11AM CST
Piper Jaffray (NYSE: PJC), a leading investment bank and asset management firm, is pleased to announce the hiring of Ruben Roy as a senior research analyst covering semiconductor and semiconductor capital equipment companies. He will be based in the firm's New York office.

Why Maxwell Technologies Inc. Shares Skyrocketed Today
Steve Symington, The Motley Fool - Motley Fool - Wed Mar 05, 6:41PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of Maxwell Technologies jumped nearly 23%...

Surging Rank, Surging Stock: Why GAIN Capital Holdings (GCAP) Is a Winner? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:30AM CST
GAIN Capital Holdings (GCAP) sees rank surges as well as price appreciation, as the stock price has moved higher by 16.1% in the past month.

GAIN Capital Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 3:20PM CST
On Mar 1, Zacks Investment Research upgraded GAIN Capital Holdings, Inc. (GCAP) to a Zacks Rank #1 (Strong Buy).

Can Business Spending Relieve the Consumer? - Real Time Insight
John Blank - Zacks Investment Research - Fri Feb 28, 8:50AM CST
With a Two Year Federal Budget Deal Done, Will Business Step Up?

TD Ameritrade: Rewards Aplenty If Risks Absorbed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 6:15PM CST
On Feb 21, 2014, we issued an updated research report on TD Ameritrade Holding Corporation.

SkyBitz(R) and Vnomics(R) Partner to Deliver Increased Efficiencies and Savings for Fleet Managers
Business Wire - Wed Feb 26, 7:01AM CST
Vnomics(R), a leading provider of fleet management solutions, and SkyBitz(R), the leader in remote asset tracking and information management solutions, today announced a partnership resulting in an integrated tracking solution that will provide for-hire and private fleet carriers with a more robust and time-saving solution for managing their fleets.

Balanced Risk-Reward for Interactive Brokers - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 6:10PM CST
On Feb 21, 2014, we issued an updated research report on Interactive Brokers Group, Inc.

Stifel Financial Q4 Earnings Beat on High Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 9:40AM CST
Driven by record revenues, Stifel Financial Corp. (SF) reported fourth-quarter 2013 non-GAAP net income from continuing operations of 79 cents per share, significantly surpassing the Zacks Consensus Estimate of 66 cents.

Piper Jaffray to Host Technology, Media & Telecommunications Conference
Business Wire - Mon Feb 24, 2:36PM CST
Piper Jaffray (NYSE: PJC), a leading investment bank and asset management firm, is scheduled to host its Technology, Media & Telecommunications (TMT) Conference, March 11-12, 2014 in New York.

Protein Crystallization & Crystallography Market worth $1,253 Million by 2018
PR Newswire - Thu Feb 13, 7:30AM CST
The "Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market, estimates and forecasts of revenue, and share analysis.

Piper Jaffray's board elects Scott Taylor as director
M2 - Fri Feb 07, 3:53AM CST
Piper Jaffray (NYSEJC), an investment bank and asset management firm, disclosed on Thursday that Scott Taylor joined its board of directors on 4 February 2014.

Scott Taylor Elected to Piper Jaffray Companies Board of Directors
Business Wire - Thu Feb 06, 11:45AM CST
Piper Jaffray (NYSEJC), a leading investment bank and asset management firm, announced that Scott Taylor joined its board of directors, effective February 4, 2014.

NYSE stocks posting largest percentage increases
AP - Wed Jan 29, 1:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:

Piper Jaffray Companies Announces 2013 Fourth Quarter and Year-end Results
Business Wire - Wed Jan 29, 7:00AM CST
Piper Jaffray Companies (NYSE: PJC) today announced its financial results for the quarter ended December 31, 2013.

Piper Jaffray Companies to Hold Management Conference Call to Discuss 2013 Fourth Quarter and Year-End Results
Business Wire - Tue Jan 21, 12:03PM CST
Piper Jaffray (NYSE: PJC) announced today that it will release its 2013 fourth quarter and year-end results prior to the opening of the market on Wednesday, January 29, 2014. The company will also hold a conference call to review the financial results at 9:00 a.m. ET (8:00 a.m. CT). Andrew S. Duff, chairman and chief executive officer, and Debbra L. Schoneman, chief financial officer, will host the call.

Masvingo Wants Tongaat to Surrender 10000 Hectares
by George Maponga - All Africa Global Media - Thu Jan 09, 10:33PM CST
Masvingo'S political leadership has written to Government seeking the nod to acquire 10 000 hectares of land from sugar producer Tongaat Hulett for resettlement purposes.

Piper Sandler Companies (PIPR) Stock Research Links

PIPR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 4

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Soleno Therapeutics Celebrates FDA Approval of VYKAT XR for PWS

Updated Category News Views 420

Soleno Therapeutics Announces FDA Approval for VYKAT XR Soleno Therapeutics, Inc. (NASDAQ: SLNO), a notable biopharmaceutical company, has made a significant announcement regarding the U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets. This new treatment targets hyperphagia in individuals aged four and older...

Continue Reading
aTyr Pharma Faces Legal Challenges: Investors Urged to Act

Updated Category News Views 173

aTyr Pharma's Legal Situation and Its Implications Recent developments surrounding aTyr Pharma, Inc. (NASDAQ: ATYR) have caught the attention of investors, particularly as the company faces significant legal challenges. The situation arose from a steep decline in share value triggered by disappointing results from a key clinical trial. This decline, marked by an...

Continue Reading
Primo Brands Boosts Share Repurchase Program by $50 Million

Updated Category News Views 145

Primo Brands Boosts Share Repurchase Program Primo Brands Corporation (NYSE: PRMB) is excited to announce a significant increase in its share repurchase program. This decision, made by the Board of Directors, involves raising the repurchase authorization by $50 million, bringing the total program authorization to an impressive $300 million. This enhancement in the share...

Continue Reading
GOTRAX Partners with RSMG Select to Inspire Youth Movement

Updated Category News Views 83

GOTRAX Teams Up with RSMG Select for Youth Development GOTRAX has embarked on an inspiring journey through its partnership with RSMG Select, aimed at nurturing not just young athletes but the community at large. The collaboration has transformed the experience for youth participating in futsal, allowing for significant growth and empowerment beyond the typical sports...

Continue Reading
Zenas BioPharma Celebrates Major Milestones in Q3 2025

Updated Category News Views 245

Zenas BioPharma Celebrates Major Milestones in Q3 2025 - Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end. - Reported highly positive 12-week primary endpoint results from Phase 2 MoonStone trial of obexelimab in Relapsing MS (RMS). - Secured development and commercialization rights for three...

Continue Reading